BRPI0806400A8 - composto, composição farmacêutica, produtos, usos de pelo menos um composto, método in vitro, kit, ligantes e processo de preparação de um composto - Google Patents

composto, composição farmacêutica, produtos, usos de pelo menos um composto, método in vitro, kit, ligantes e processo de preparação de um composto

Info

Publication number
BRPI0806400A8
BRPI0806400A8 BRPI0806400A BRPI0806400A BRPI0806400A8 BR PI0806400 A8 BRPI0806400 A8 BR PI0806400A8 BR PI0806400 A BRPI0806400 A BR PI0806400A BR PI0806400 A BRPI0806400 A BR PI0806400A BR PI0806400 A8 BRPI0806400 A8 BR PI0806400A8
Authority
BR
Brazil
Prior art keywords
compound
binders
kit
preparing
products
Prior art date
Application number
BRPI0806400A
Other languages
English (en)
Inventor
De Libero Gennaro
Puzo Germain
Prandi Jacques
Guiard Julie
Mori Lucia
Gilleron Martine
Paoletti Samantha
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of BRPI0806400A2 publication Critical patent/BRPI0806400A2/pt
Publication of BRPI0806400A8 publication Critical patent/BRPI0806400A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

composto, composição farmacêutica, produtos, usos de pelo menos um composto, método in vitro, kit, ligantes e processo de preparação de um composto. a presente invenção trata de compostos que têm a fórmula geral (1), de seu processo de preparação e de seu uso no tratamento ou na profilaxia da tuberculose.
BRPI0806400A 2007-01-24 2008-01-11 composto, composição farmacêutica, produtos, usos de pelo menos um composto, método in vitro, kit, ligantes e processo de preparação de um composto BRPI0806400A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07290097.0 2007-01-24
EP07290097A EP1950218A1 (en) 2007-01-24 2007-01-24 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis
PCT/IB2008/000053 WO2008090425A1 (en) 2007-01-24 2008-01-11 Sulfoglycolipid antigens, their process of preparation, and their use against tuberculosis

Publications (2)

Publication Number Publication Date
BRPI0806400A2 BRPI0806400A2 (pt) 2011-09-06
BRPI0806400A8 true BRPI0806400A8 (pt) 2018-10-23

Family

ID=38080940

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0806400A BRPI0806400A8 (pt) 2007-01-24 2008-01-11 composto, composição farmacêutica, produtos, usos de pelo menos um composto, método in vitro, kit, ligantes e processo de preparação de um composto

Country Status (7)

Country Link
US (1) US8268801B2 (pt)
EP (2) EP1950218A1 (pt)
JP (1) JP5547491B2 (pt)
CN (1) CN101622266B (pt)
BR (1) BRPI0806400A8 (pt)
ES (1) ES2659516T3 (pt)
WO (1) WO2008090425A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288509B2 (en) * 2002-02-22 2012-10-16 National Hospital Organization Kinki-chuo Chest Medical center Therapeutic agent for infections, and treatment method using the same
JP6195848B2 (ja) 2012-01-27 2017-09-13 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ 糖ポリマーを用いた生体分子の安定化
JP6276806B2 (ja) * 2016-05-30 2018-02-07 マイクロ波化学株式会社 ショ糖脂肪酸エステルの製造方法
JP5952980B1 (ja) * 2016-02-17 2016-07-13 マイクロ波化学株式会社 ショ糖ステアリン酸エステルの製造方法
WO2016194887A1 (ja) * 2015-06-01 2016-12-08 マイクロ波化学株式会社 ショ糖脂肪酸エステルの製造方法
JP5945756B1 (ja) * 2015-06-01 2016-07-05 マイクロ波化学株式会社 ショ糖脂肪酸エステルの製造方法
NL2016913B1 (en) * 2016-06-08 2017-12-18 Kei International Ltd Solid substrate comprising antigens immobilised thereto and use thereof in a method for detecting the presence of mycobacterial material in a sample
NL2017204B1 (en) * 2016-06-08 2017-12-18 Kei International Ltd Solid substrate comprising antigens immobilised thereto, biosensor comprising said solid substrate and method for detecting the presence of mycobacterial material in a sample
WO2017211316A1 (en) 2016-06-08 2017-12-14 Kei International Limited Method for detecting the presence of mycobacterial material in a sample using at least two antigens
NL2021443B1 (en) 2018-08-08 2020-02-20 Kei International Ltd Synthetic antigens for tuberculosis detection
NL2022166B1 (en) 2018-12-10 2020-07-02 Kei International Ltd Nitrocellulose sheet comprising immobilized immunoglobulins and lipid based antigens and use thereof
FR3092113B1 (fr) * 2019-01-29 2023-04-21 Arkema France Huile de base lubrifiante synthetisee a partir desters d’alcool de sucre
FR3092112B1 (fr) * 2019-01-29 2023-01-06 Arkema France Huile de base lubrifiante synthetisee a partir d’esters de polyols et d’acides gras biosources

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1469007A1 (en) * 2003-04-18 2004-10-20 Centre National De La Recherche Scientifique (Cnrs) Sulfoglycolipid antigens, their extraction from mycobacterieum tuberculosis, and their use against tuberculosis

Also Published As

Publication number Publication date
EP2125849A1 (en) 2009-12-02
ES2659516T3 (es) 2018-03-16
JP5547491B2 (ja) 2014-07-16
US8268801B2 (en) 2012-09-18
CN101622266B (zh) 2013-09-11
EP1950218A1 (en) 2008-07-30
BRPI0806400A2 (pt) 2011-09-06
EP2125849B1 (en) 2017-11-15
US20100166801A1 (en) 2010-07-01
JP2010516748A (ja) 2010-05-20
WO2008090425A1 (en) 2008-07-31
CN101622266A (zh) 2010-01-06

Similar Documents

Publication Publication Date Title
BRPI0806400A8 (pt) composto, composição farmacêutica, produtos, usos de pelo menos um composto, método in vitro, kit, ligantes e processo de preparação de um composto
BRPI0910439B8 (pt) derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos
BRPI0717970B8 (pt) composto inibidor de 11betahsd1, composição farmacêutica, e, uso do composto
BRPI0910832B8 (pt) derivados de tienopiridona como ativadores de proteína quinase ativada por amp (ampk), seus usos, seu processo de preparação e seus intermediários, e medicamentos.
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
BR112012010706A2 (pt) composto, composição farmacêutica, combinação do produto farmacêutico, uso de um composto, e, métodos para o tratamento de uma doença ou condição, e para inibir um bromodomínio
BRPI0609719B8 (pt) derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2
BRPI0612957B8 (pt) composto, processos de preparação de compostos, composição farmacêutica e uso de um composto
BRPI0712631A8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
BR0213539A (pt) Compostos, processo para a preparação de compostos, composições farmacêuticas que compreendem um composto método para o tratamento e/ou profilaxia de enfermidades que estão associadas com dpp iv e utilização desses compostos
BR0312398A (pt) Derivado de 1,3-difenilprop-2-en-1-ona substituìdo, processo de preparação de compostos, composição farmacêutica e utilização de pelo menos um derivado de 1,3-difenilprop-2-en-1-ona substituìdo
BRPI0410238A (pt) compostos orgánicos
BRPI0921482A8 (pt) Uso de uma construção de anticorpo de cadeia simples biespecífica cd19xcd3 no tratamento de leucemia linfoblástica aguda
UY31046A1 (es) Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones
CL2012001391A1 (es) Compuestos derivados de triazolopiridina sustituidos, inhibidores de la quinasa mps-1; composición farmacéutica; procedimiento de preparacion; combinación farmacéutica y uso para la profilaxis o tratamiento de una enfermedad hiperproliferativa tal como tumores hematológicos, sólidos y/o sus metástasis; compuestos intermediarios.
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
BRPI0510273A (pt) derivados de tetraazabenzo[e]azuleno e análogos destes
BRPI0709633B8 (pt) derivados de piridina e pirimidina como antagonistas de mglur2, composição farmacêutica e uso dos mesmos
BRPI0907789A2 (pt) derivaldos 16-alfa e 17-alfa de glicocorticosteroides e seus usos
BRPI0510410A (pt) compostos orgánicos
BRPI0514438A (pt) composto, composição farmacêutica, uso de um composto, método para o tratamento ou profilaxia de uma condição ou doença moduladas por um receptor de quimiocina, e, processo para a preparação do composto
BRPI0908406B8 (pt) Derivados de quinoxalinona, processo para a preparação dos mesmos, seu uso e composição farmacêutica
BRPI0519106A2 (pt) compostos, uso destes, processo para sua fabricaÇço, composiÇÕes farmacÊuticas, mÉtodo para o tratamento e/ou profilaxia de doenÇas que sço associadas com a dpp-iv
BRPI0618479A2 (pt) pirrolpiridinas composição farmacêutica que as contém
BRPI0712889A8 (pt) composto, processo para a preparação de um composto, composto intermediário, e, composição farmacêutica.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements